MEM 2025

It's been a long road for the company. I've been in and out and been very vocal on the stock. Management up until 2023 has been lacking and Alison we all know was a scientist not a CEO. She even threw her hands up in bewilderment in an investor presentation asking what does the market want? We we all know, sales. $$$$ and progress. The TGA delays have killed the company's progress and lack of sales does not put confidence in the markets' opinion for the company to grow these sales.

I truly believe that FY 2025 is going to be a great year for MEM. It won't be a million dollars in sales, but it will show the companies growth. That growth will give back the market confidence that it needs. David has taken his time to sit back and look at the big picture. What has he achieved so far? Well, he's looked at the bottom line and said, this is not sustainable with the overheads. He has reduced non-essential staff, saw that we were in a building much greater building than we needed and I am sure will be looking at all the ways possible to restructure and renegotiate the way the company moves forward.

So in the FY 2025 what does the company need to achieve, at a minimum?

• TGA. The never ending story this one. Study anticipated to be completed by end of December 2022. David must shake his head at this. He understands that this trial needs to be completed asap. He's working on that and since taking over, the swim up has been 100% completed. We are I believe over 60% completed with DCG, with more clinics on board we are moving this forward quickly. I believe the company has applied for non-inferior which means according to the TGA has to be at least in the 95% range of the other methods. We have all seen enough evidence that it is not only as good, but in all areas superior. Not only this but the doctor who used it in India was able to have men that were considered infertile fertilize an egg and achieve live births. I believe you can basically think of it like this. In the swim up process with low or no mobility it isn't going to happen. But the Felix almost acts like a magnet, with the charge in the sperm 'Head' being pulled through and although the mobility is not there, the DNA of that sperm is fine. This way a suitable, DNA healthy little fella can be used. The process without the Felix is a little less comfortable for the man, think of a big needle being stuck in somewhere and the potatoes being drained TGA will give us Australia. In turn with this we can then get the CE Mark for Europe and just some paperwork to get into India. Not sure on China. So without FDA which is fine for now, what is just the Felix worth in SP value? In 2020 Pitt Street did a report at the time we were 38 Mill MC. (4 years behind now and with one product in the pipeline) The thought back then was if MEM can get sales in Japan, Canada, NZ, India and Australia the MC would be up to $120-190 Mill. With dilution today that would be a 9c SP. Well we have at least got Japan at the moment.
• Next we have something that we haven't heard much on, but may well be a big SP builder for the company. Re-reading the Pitt street report we have a whole other Felix opportunity available. Animals. I am aware that the horse industry was keen but the Felix had to be redesigned for horse semen. But Pigs, sheep for example should be as is. In the top 20 we have seen a rise in WA farmers (probably friends of Bob Peters) and recently with Klean Gene Pty coming on board it seems pretty obvious that this arm is likely to start to take shape. In Europe, the pig AI rate – i.e. percentage sows mated through artificial insemination – is between 25 and 98%. In The Netherlands the pig AI rate is 98%.Nº AI doses sold 4.200.000 This is just in Europe. There are no silly TGA or CE Mark trial needed for the pigs! I think with the new Farmers and Klean Gene coming on board this year we will see some good movement in this space. I think this will be bigger revenue than Felix for humans. If 9c SP valuation is put on the Human side, I feel confident that we could double this for pigs alone. 18c
• roXsta will be also an interesting arm to MEM in 2025. Oxidative stress biomarkers are considered to be useful tools to comprehend animal welfare since stress can reduce the body’s antioxidant resources and, as a consequence, lead the animal to metabolic disorders or diseases. In dairy cows, oxidative stress biomarkers undergo wide changes in production and concentration during the different stages from pregnancy to parturition and lactation. Again this is just one area, low regulations and fast market penetration. Also there are Labs all over the world that need a fast and efficient way to measure OS. Again low regulations in this and fast and efficient testing will speed up lab research enormous amounts. I think that we will see first sales in the roXsta test prototype in FY 2025. At least worth 5-7c to the SP in that time.

So Felix in humans 9c, Felix in pigs (?) 18c and roXsta first sales 6c then we could be looking at 30c less dilution of 20%? 24c

Even if we only achieve 30% of what I think we can do in 2025 then that still looks to be around 7c SP on the first half of 2025. 7BAGS!!!!!! One for each shoulder, 2 in your backpack, 2 tied around you legs and one on top balanced on your head,


Please note this is not a real picture of a holder of MEM shares, as obviously the bags are not big enough!